Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncotarget|August 28, 2020
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBLYaya Chu, Aradhana Awasthi, Sanghoon Lee, et al.
Frontiers in Immunology|October 9, 2023
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skinMorgan Anderson-Crannage, Alex M Ascensión, Olga Ibanez-Solé, et al.
Molecular Therapy. Oncology|February 3, 2025
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastomaYaya Chu, Meijuan Tian, Uksha Saini, et al.
Molecular Therapy. Oncology|November 18, 2024
Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastomaWen Luo, Aliza Gardenswartz, Hai Hoang, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Frontiers in Immunology|December 26, 2022
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell diseaseYaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, et al.
Oncoimmunology|December 15, 2018
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) modelYaya Chu, Sanghoon Lee, Tishi Shah, et al.
The Journal of Infectious Diseases|December 30, 2022
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T LymphocytesYaya Chu, Jordan Milner, Margaret Lamb, et al.
Pageof 3